Dendritic Cell-Based Tumor Vaccines and Antigen Presentation Attenuators
Open Access
- 1 May 2006
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 13 (5) , 850-858
- https://doi.org/10.1016/j.ymthe.2006.02.009
Abstract
No abstract availableKeywords
This publication has 105 references indexed in Scilit:
- An Alternative and Effective HIV Vaccination Approach Based on Inhibition of Antigen Presentation Attenuators in Dendritic CellsPLoS Medicine, 2006
- Protein tyrosine phosphatases and the immune responseNature Reviews Immunology, 2005
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Human CD4+CD25+ regulatory T cellsSeminars in Immunology, 2004
- Current developments of immunotherapy in the clinicCurrent Opinion in Immunology, 2004
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004
- Results of clinical trials with an allogeneic melanoma tumor cell lysate vaccine: Melacine®Seminars in Cancer Biology, 2003
- Origin, precursors and differentiation of mouse dendritic cellsNature Reviews Immunology, 2003
- Mouse and human dendritic cell subtypesNature Reviews Immunology, 2002
- Dendritic cell subsets and the regulation of Th1/Th2 responsesSeminars in Immunology, 2001